Indian specialty chemicals

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Vitestro’s Aletta robotic blood-draw system has received U.S. Food and Drug Administration De Novo authorization, opening a new regulatory pathway for autonomous phlebotomy as laboratories weigh whether robotic blood collection can scale economically and operationally. Representative image.

Vitestro wins FDA De Novo authorization for Aletta robotic blood draw system

Baidu’s second-quarter 2026 results highlight the tension in its AI transition, with AI Cloud Infrastructure revenue rising 50% and GPU Cloud revenue surging 283% even as legacy businesses weakened and total revenue declined 4%. Representative image.

Baidu GPU cloud surges 283%, but investors punish unfinished AI transition

A66 wrong-way crash kills seven including two Cleveland Police officers near Middlesbrough

Construction of President Donald Trump’s $400 million White House ballroom can continue temporarily after Chief Justice John Roberts stayed a lower-court injunction, keeping the controversial 90,000-square-foot project moving while the dispute over congressional approval remains unresolved. Representative image.

Trump White House ballroom survives immediate shutdown after Supreme Court stay

Representative image: Manali Petrochemicals’ FY26 profit rebound highlights the company’s push toward higher-value specialty chemicals, improved raw material discipline and renewed investor focus on #MANALIPETC after a sharp earnings recovery.

Manali Petrochemicals FY26 profit surge puts #MANALIPETC turnaround under investor watch

Manali Petrochemicals’ profit rebound is real, but #MANALIPETC still trades far below its 52-week high. Read what changes next.

byVenkatesh

May 21, 2026

Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures

Galaxy Surfactants Limited Q3 FY26 results reveal how specialty care growth is offsetting global surfactant pressure. Find out what this means for investors.

byVenkatesh

February 14, 2026

The Latest

Vitestro wins FDA De Novo authorization for Aletta robotic blood draw system

Baidu GPU cloud surges 283%, but investors punish unfinished AI transition

A66 wrong-way crash kills seven including two Cleveland Police officers near Middlesbrough

Trump White House ballroom survives immediate shutdown after Supreme Court stay

Manali Petrochemicals FY26 profit surge puts #MANALIPETC turnaround under investor watch

Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures

Vitestro wins FDA De Novo authorization for Aletta robotic blood draw system

Baidu GPU cloud surges 283%, but investors punish unfinished AI transition

A66 wrong-way crash kills seven including two Cleveland Police officers near Middlesbrough

Trump White House ballroom survives immediate shutdown after Supreme Court stay

Saudi Arabia signs $1.16bn battery deals for 2GW and 8GWh of grid storage

RMC Switchgears (NSE: RMC) wins Rs 344cr orders as Q1 revenue plunges 56%

Ithaca Energy (LSE: ITH) lifts 2026 dividend as Rosebank moves toward first oil

Can Euler Motors fill a 24,000-unit factory while moving toward breakeven?